;PMID: 1714839
;source_file_2851.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..39] = [t:0..39]
;1)sentence:[e:45..105] = [t:45..105]
;2)section:[e:109..127] = [t:109..127]
;3)section:[e:131..222] = [t:131..222]
;4)sentence:[e:226..508] = [t:226..508]
;5)sentence:[e:509..697] = [t:509..697]
;6)sentence:[e:699..886] = [t:699..886]
;7)sentence:[e:887..984] = [t:887..984]
;8)sentence:[e:985..1300] = [t:985..1300]
;9)section:[e:1304..1348] = [t:1304..1348]

;section 0 Span:0..39
;Endocrinology.  1991 Sep;129(3):1682-4.
(SEC
  (FRAG (RB:[0..13] Endocrinology) (JJ:[13..14] .) (CD:[16..20] 1991)
        (CC:[21..29] Sep;129-LRB-) (CD:[29..30] 3) (-RRB-:[30..31] -RRB-)
        (CD:[31..36] :1682) (CD:[36..39] -4.)))

;sentence 1 Span:45..105
;Human galanin: molecular cloning reveals a unique structure.
;[51..58]:gene-protein:"galanin"
(SENT
  (FRAG-HLN
    (NP (JJ:[45..50] Human) (NN:[51..58] galanin))
    (::[58..59] :)
    (S
      (NP-SBJ (JJ:[60..69] molecular) (NN:[70..77] cloning))
      (VP (VBZ:[78..85] reveals)
        (NP (DT:[86..87] a) (JJ:[88..94] unique) (NN:[95..104] structure))))
    (.:[104..105] .)))

;section 2 Span:109..127
;Evans HF, Shine J.
(SEC
  (FRAG (NNP:[109..114] Evans) (NNP:[115..117] HF) (,:[117..118] ,)
        (NNP:[119..124] Shine) (NNP:[125..127] J.)))

;section 3 Span:131..222
;Garvan Institute of Medical Research, St Vincent's Hospital, Darlinghurst,
;NSW,  Australia.
(SEC
  (FRAG (NNP:[131..137] Garvan) (NNP:[138..147] Institute) (IN:[148..150] of)
        (NNP:[151..158] Medical) (NNP:[159..167] Research) (,:[167..168] ,)
        (NNP:[169..171] St) (NNP:[172..179] Vincent) (POS:[179..181] 's)
        (NNP:[182..190] Hospital) (,:[190..191] ,) (NNP:[192..204] Darlinghurst)
        (,:[204..205] ,) (NNP:[206..209] NSW) (,:[209..210] ,)
        (NNP:[212..221] Australia) (.:[221..222] .)))

;sentence 4 Span:226..508
;Galanin, a novel neuropeptide/hypothalamic hormone originally identified and 
;isolated by virtue of its carboxy-terminal amide group, has recently been
;shown  to have a diverse range of biological activities, including potent
;effects on  the secretion of insulin and growth hormone.
;[226..233]:gene-protein:"Galanin"
;[481..488]:gene-protein:"insulin"
;[493..507]:gene-protein:"growth hormone"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NP (NN:[226..233] Galanin))
        (,:[233..234] ,)
        (NP
          (NP (DT:[235..236] a) (JJ:[237..242] novel)
              (NN:[243..255] neuropeptide))
          (SYM:[255..256] /)
          (NP (JJ:[256..268] hypothalamic) (NN:[269..276] hormone))))
      (VP
        (ADVP (RB:[277..287] originally))
        (VBN:[288..298] identified) (CC:[299..302] and)
         (VBN:[304..312] isolated)
        (NP (-NONE-:[312..312] *))
        (PP (IN:[313..315] by)
          (NP
            (NP (NN:[316..322] virtue))
            (PP (IN:[323..325] of)
              (NP (PRP$:[326..329] its)
                (NML (NN:[330..337] carboxy) (HYPH:[337..338] -)
                     (JJ:[338..346] terminal))
                (NN:[347..352] amide) (NN:[353..358] group)))))))
    (,:[358..359] ,)
    (VP (VBZ:[360..363] has)
      (ADVP-TMP (RB:[364..372] recently))
      (VP (VBN:[373..377] been)
        (VP (VBN:[378..383] shown)
          (S
            (NP-SBJ-1 (-NONE-:[383..383] *))
            (VP (TO:[385..387] to)
              (VP (VB:[388..392] have)
                (NP
                  (NP (DT:[393..394] a) (JJ:[395..402] diverse)
                      (NN:[403..408] range))
                  (PP (IN:[409..411] of)
                    (NP
                      (NP (JJ:[412..422] biological) (NNS:[423..433] activities))
                      (,:[433..434] ,)
                      (PP (VBG:[435..444] including)
                        (NP
                          (NP (JJ:[445..451] potent) (NNS:[452..459] effects))
                          (PP (IN:[460..462] on)
                            (NP
                              (NP
                                (NP (DT:[464..467] the)
                                    (NN:[468..477] secretion))
                                (PP (IN:[478..480] of)
                                  (NP (NN:[481..488] insulin))))
                              (CC:[489..492] and)
                              (NP (NN:[493..499] growth) (NN:[500..507] hormone)))))))))))))))
    (.:[507..508] .)))

;sentence 5 Span:509..697
;The physiological role of galanin  remains unclear, with different effects
;being observed when porcine and rat  galanin have been used in various animal
;model systems and in human studies.
;[535..542]:gene-protein:"galanin"
;[621..628]:gene-protein:"galanin"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[509..512] The) (JJ:[513..526] physiological) (NN:[527..531] role))
      (PP (IN:[532..534] of)
        (NP (NN:[535..542] galanin))))
    (VP (VBZ:[544..551] remains)
      (ADJP-PRD (JJ:[552..559] unclear))
      (,:[559..560] ,)
      (PP (IN:[561..565] with)
        (S-NOM
          (NP-SBJ-1 (JJ:[566..575] different) (NNS:[576..583] effects))
          (VP (VBG:[584..589] being)
            (VP (VBN:[590..598] observed)
              (NP-1 (-NONE-:[598..598] *))
              (SBAR-ADV
                (WHADVP-3 (WRB:[599..603] when))
                (S
                  (NP-SBJ-2
                    (NP (JJ:[604..611] porcine))
                    (CC:[612..615] and)
                    (NP (NN:[616..619] rat) (NN:[621..628] galanin)))
                  (VP (VBP:[629..633] have)
                    (VP (VBN:[634..638] been)
                      (VP (VBN:[639..643] used)
                        (NP-2 (-NONE-:[643..643] *))
                        (PP
                          (PP (IN:[644..646] in)
                            (NP (JJ:[647..654] various) (NN:[655..661] animal)
                                (NN:[662..667] model) (NNS:[668..675] systems)))
                          (CC:[676..679] and)
                          (PP (IN:[680..682] in)
                            (NP (JJ:[683..688] human) (NNS:[689..696] studies))))
                        (ADVP-TMP-3 (-NONE-:[696..696] *T*))))))))))))
    (.:[696..697] .)))

;sentence 6 Span:699..886
;Molecular cloning of cDNA encoding human galanin and galanin mRNA associated 
;peptide (GMAP) from both pituitary and neuroblastoma sources has revealed a 
;unique and unexpected structure.
;[740..747]:gene-protein:"galanin"
;[752..784]:gene-protein:"galanin mRNA associated  peptide"
;[786..790]:gene-protein:"GMAP"
;[816..829]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[699..708] Molecular) (NN:[709..716] cloning))
      (PP (IN:[717..719] of)
        (NP
          (NP
            (NP
              (ADJP (NN:[720..724] cDNA) (VBG:[725..733] encoding))
              (JJ:[734..739] human) (NN:[740..747] galanin))
            (CC:[748..751] and)
            (NP
              (NP
                (NML (NN:[752..759] galanin) (NN:[760..764] mRNA)
                     (VBN:[765..775] associated))
                (NN:[777..784] peptide))
              (NP (-LRB-:[785..786] -LRB-) (NN:[786..790] GMAP)
                  (-RRB-:[790..791] -RRB-))))
          (PP (IN:[792..796] from)
            (NP (CC:[797..801] both)
              (NP (JJ:[802..811] pituitary)
                (NML-1 (-NONE-:[811..811] *P*)))
              (CC:[812..815] and)
              (NP (NN:[816..829] neuroblastoma)
                (NML-1 (NNS:[830..837] sources))))))))
    (VP (VBZ:[838..841] has)
      (NP (VBD:[842..850] revealed)
        (NP (DT:[851..852] a)
          (ADJP (JJ:[854..860] unique) (CC:[861..864] and)
                (JJ:[865..875] unexpected))
          (NN:[876..885] structure))))
    (.:[885..886] .)))

;sentence 7 Span:887..984
;In contrast to porcine, bovine and rodent  galanin, human galanin lacks a
;carboxy-terminal amide.
;[930..937]:gene-protein:"galanin"
;[945..952]:gene-protein:"galanin"
(SENT
  (S
    (PP (IN:[887..889] In)
      (NP
        (NP (NN:[890..898] contrast))
        (PP (TO:[899..901] to)
          (NP
            (NP (JJ:[902..909] porcine)
              (NML-1 (-NONE-:[909..909] *P*)))
            (,:[909..910] ,)
            (NP (JJ:[911..917] bovine)
              (NML-1 (-NONE-:[917..917] *P*)))
            (CC:[918..921] and)
            (NP (NN:[922..928] rodent)
              (NML-1 (NN:[930..937] galanin)))))))
    (,:[937..938] ,)
    (NP-SBJ (JJ:[939..944] human) (NN:[945..952] galanin))
    (VP (VBZ:[953..958] lacks)
      (NP (DT:[959..960] a)
        (NML (NN:[961..968] carboxy) (HYPH:[968..969] -)
             (JJ:[969..977] terminal))
        (NN:[978..983] amide)))
    (.:[983..984] .)))

;sentence 8 Span:985..1300
;By analogy to other  neurohormones, the absence of carboxy-terminal amidation
;would be expected to  have significant effects on functional properties such
;as affinity for different  receptor subtypes and physiological half life, and
;may be responsible for the  species specificity observed in the action of
;galanin.
;[1292..1299]:gene-protein:"galanin"
(SENT
  (S
    (PP (IN:[985..987] By)
      (NP
        (NP (NN:[988..995] analogy))
        (PP (TO:[996..998] to)
          (NP (JJ:[999..1004] other) (NNS:[1006..1019] neurohormones)))))
    (,:[1019..1020] ,)
    (NP-SBJ-1
      (NP (DT:[1021..1024] the) (NN:[1025..1032] absence))
      (PP (IN:[1033..1035] of)
        (NP
          (NML (NN:[1036..1043] carboxy) (HYPH:[1043..1044] -)
               (JJ:[1044..1052] terminal))
          (NN:[1053..1062] amidation))))
    (VP
      (VP (MD:[1063..1068] would)
        (VP (VB:[1069..1071] be)
          (VP (VBN:[1072..1080] expected)
            (S
              (NP-SBJ-1 (-NONE-:[1080..1080] *))
              (VP (TO:[1081..1083] to)
                (VP (VB:[1085..1089] have)
                  (NP
                    (NP (JJ:[1090..1101] significant) (NNS:[1102..1109] effects))
                    (PP (IN:[1110..1112] on)
                      (NP
                        (NP (JJ:[1113..1123] functional)
                            (NNS:[1124..1134] properties))
                        (PP (JJ:[1135..1139] such) (IN:[1140..1142] as)
                          (NP
                            (NP
                              (NP (NN:[1143..1151] affinity))
                              (PP (IN:[1152..1155] for)
                                (NP (JJ:[1156..1165] different)
                                    (NN:[1167..1175] receptor)
                                    (NNS:[1176..1184] subtypes))))
                            (CC:[1185..1188] and)
                            (NP (JJ:[1189..1202] physiological)
                                (NN:[1203..1207] half) (NN:[1208..1212] life)))))))))))))
      (,:[1212..1213] ,) (CC:[1214..1217] and)
      (VP (MD:[1218..1221] may)
        (VP (VB:[1222..1224] be)
          (ADJP-PRD (JJ:[1225..1236] responsible)
            (PP (IN:[1237..1240] for)
              (NP
                (NP (DT:[1241..1244] the) (NN:[1246..1253] species)
                    (NN:[1254..1265] specificity))
                (VP (VBN:[1266..1274] observed)
                  (NP (-NONE-:[1274..1274] *))
                  (PP (IN:[1275..1277] in)
                    (NP
                      (NP (DT:[1278..1281] the) (NN:[1282..1288] action))
                      (PP (IN:[1289..1291] of)
                        (NP (NN:[1292..1299] galanin))))))))))))
    (.:[1299..1300] .)))

;section 9 Span:1304..1348
;PMID: 1714839 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1304..1308] PMID) (::[1308..1309] :) (CD:[1310..1317] 1714839)
        (NN:[1318..1319] -LSB-) (NNP:[1319..1325] PubMed) (::[1326..1327] -)
        (NN:[1328..1335] indexed) (IN:[1336..1339] for)
        (NNP:[1340..1348] MEDLINE-RSB-)))
